Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 451 AL 465

[Current status of Alzheimer's disease immunotherapy and pharmacologic effect of BAN2401.]

Araki S.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):21-5. doi: 10.1254/fpj.136.21.

The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions

Keller L, Welander H, Chiang HH, Tjernberg LO, Nennesmo I, Wallin AK, Graff C.

Eur J Hum Genet. 2010 Nov;18(11):1202-8. doi: 10.1038/ejhg.2010.107. Epub 2010 Jul 14.

Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease

Re F, Airoldi C, Zona C, Masserini M, La Ferla B, Quattrocchi N, Nicotra F.

Curr Med Chem. 2010;17(27):2990-3006. doi: 10.2174/092986710791959729.

Kynurenines, neurodegeneration and Alzheimer's disease

Kincses ZT, Toldi J, Vécsei L.

J Cell Mol Med. 2010 Aug;14(8):2045-54. doi: 10.1111/j.1582-4934.2010.01123.x. Epub 2010 Jul 12.

Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis

Boche D, Denham N, Holmes C, Nicoll JA.

Acta Neuropathol. 2010 Sep;120(3):369-84. doi: 10.1007/s00401-010-0719-5. Epub 2010 Jul 15.

Neuroinflammatory processes in Alzheimer's disease

Heneka MT, O'Banion MK, Terwel D, Kummer MP.

J Neural Transm (Vienna). 2010 Aug;117(8):919-47. doi: 10.1007/s00702-010-0438-z. Epub 2010 Jul 15.

Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein

Singh M, Dang TN, Arseneault M, Ramassamy C.

J Alzheimers Dis. 2010;21(3):741-56. doi: 10.3233/JAD-2010-100405.

A review of string vessels or collapsed, empty basement membrane tubes

Brown WR.

J Alzheimers Dis. 2010;21(3):725-39. doi: 10.3233/JAD-2010-100219.

Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma

Oh ES, Mielke MM, Rosenberg PB, Jain A, Fedarko NS, Lyketsos CG, Mehta PD.

J Alzheimers Dis. 2010;21(3):769-73. doi: 10.3233/JAD-2010-100456.

Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis

Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J.

J Alzheimers Dis. 2010;21(3):843-51. doi: 10.3233/JAD-2010-100078.

Immunotherapy and neuroimmunology in Alzheimer's disease: a perspective from the blood-brain barrier

Banks WA.

Immunotherapy. 2010 Jan;2(1):1-3. doi: 10.2217/imt.09.72.

Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats

Baraka A, ElGhotny S.

Eur J Pharmacol. 2010 Sep 1;641(2-3):123-7. doi: 10.1016/j.ejphar.2010.05.030. Epub 2010 Jun 8.

Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease

Melchior B, Garcia AE, Hsiung BK, Lo KM, Doose JM, Thrash JC, Stalder AK, Staufenbiel M, Neumann H, Carson MJ.

ASN Neuro. 2010 Jul 12;2(3):e00037. doi: 10.1042/AN20100010.

Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications

Creed MC, Milgram NW.

Age (Dordr). 2010 Sep;32(3):365-84. doi: 10.1007/s11357-010-9142-z. Epub 2010 Apr 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias